SWX:UBSN 24 November 2025

Swiss Stock Market Today, November 24, 2025: SMI Edges Higher as Tech Stocks Rally and UBS Legal Cases Weigh on Banks

The Swiss Market Index rose about 0.4% to 0.5% to near 12,680 on Monday, buoyed by global rate-cut hopes despite legal headlines around UBS and weak macro data. Logitech led blue-chip gains, up 3.6%, while ABB and Richemont also advanced. Defensive stocks like Roche and Swiss Re lagged. The SMI remains up roughly 8–9% for the year.

24 November 2025

Stock Market·SWX:ABBN·SWX:CFR·SWX:LOGN·SWX:UBSN

Sun Pharma Shares Under Pressure After Trump Imposes Tariffs on Imported Drugs
April 3, 2026, 4:11 AM EDT. Sun Pharma shares will be closely watched after President Trump issued an executive order imposing 100% tariffs on imported branded pharmaceuticals unless manufacturers cut prices or produce locally. Although generic drugs are exempt and some big pharma firms have negotiated to avoid tariffs, mid-sized companies like Sun Pharma face risks. Jefferies notes Sun Pharma earns about 20% of its revenue from innovative drugs produced mainly in South Korea, the EU, or the U.S.-regions subject to a 15% tariff, capping potential impact. The stock dropped nearly 2% to ₹1,694.65 on April 2 but showed signs of buying interest Friday, suggesting possible short-term recovery towards ₹1,730-₹1,750. Immediate support is at ₹1,640, key for sustaining any rebound.